Female Underrepresentation and Higher Mortality in AVR Remains: Part 2 - TAVR

Read full text Summarise with VIRAT
Authors: Tang M, Rajesh Prabhakar Bhavsar, Lassen JF, Nielsen PH, Carl-Johan Jakobsen
Cited by: 0
References: 40

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Aortic stenosis is a progressive and degenerative disease, which at some stage needs an aortic valve replacement (AVR). Despite an almost equal prevalence of aortic stenosis, female referral to AVR is lower and unexplained, although partly explained in the differences in risk and outcome. The introduction of transcatheter aortic valve replacement (TAVR) increased the treatment palette of especially of older and high-risk patients. It was suggested that lower female referral would likely change as primary result of TAVR showed survival in women than men. 1.2. Methods and results: Data of 3,863 first time stand-alone TAVR patients from 2007-2020 was obtained from the mandatory West Denmark Heart Registry. TAVR increased from 400 in 2007- 2011 to 1648 in 2018-2020, while female fraction declined from 56.0% to 42.7%. Females were older but with significant less comorbidity and generally were found significant differences in most pre-operative parameters between genders. Females more often suffered stroke (3.35 vs 2.19; P=0.035) and bleeding issues (3.01 vs 1.76; P=0.011). The 30-day mortality was higher (3.57 vs 2.81) in females, but both 1- (9.6 vs 11.0) and 5-year mortality (42.5 vs 51.0) was significantly lower in females than men. The mortality in general was high to the very old population undergoing TAVR.

Fields of Study & Subjects

Cardiac Valve Diseases and Treatments Aortic Disease and Treatment Approaches Infective Endocarditis Diagnosis and Management

Publication details

Journal / source
Clinics of Surgery
Volume
11
Issue
01
Pages
01–11
Publication date
1 January 2026
Language
EN